Standard Family Office’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6
| Closed | -$4K | – | 350 |
|
|
2022
Q3 | $4K | Hold |
6
| – | – | ﹤0.01% | 331 |
|
|
2022
Q2 | $4K | Buy |
+6
| New | +$4K | 0.04% | 134 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | -$3K | – | 211 |
|
|
2021
Q4 | $3K | Buy |
+5
| New | +$3K | 0.03% | 172 |
|
|
2021
Q3 | – | Sell |
-5
| Closed | -$3K | – | 425 |
|
|
2021
Q2 | $3K | Hold |
5
| – | – | ﹤0.01% | 320 |
|
|
2021
Q1 | $2K | Hold |
5
| – | – | ﹤0.01% | 463 |
|
|
2020
Q4 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 477 |
|